Brief: Sabra Reports Q2 2021 Results

Sabra Health Care REIT

04/08/2021 21:16

Aug 4 (Reuters) - Sabra Health Care REIT Inc  SBRA.O :
    * SABRA REPORTS SECOND QUARTER 2021 RESULTS; ANNOUNCES
INTENT TO
EXIT ITS ENLIVANT JOINT VENTURE INVESTMENT; PROVIDES BUSINESS
UPDATE AND 2021 GUIDANCE
    * EXPECT TO SELL 49% EQUITY INTEREST IN ENLIVANT JOINT
VENTURE
SHOULD TPG SECURE A BUYER FOR PORTFOLIO SOMETIME IN FUTURE
    * SABRA -  REVISITED ESTIMATED FAIR VALUE OF ENLIVANT JOINT
VENTURE INVESTMENT AND RECOGNIZED AN IMPAIRMENT CHARGE OF $164.1
MILLION IN QUARTER
    * QTRLY FFO, NORMALIZED FFO, AFFO AND NORMALIZED AFFO PER
DILUTED
COMMON SHARE WERE $0.39, $0.41, $0.39, $0.40, RESPECTIVELY
    * Q2 FFO PER SHARE VIEW $0.39 -- REFINITIV IBES DATA
    * SEES FY FFO PER SHARE $1.53 - $1.55
    * SEES FY NFFO EARNINGS PER SHARE $1.56 - $1.58
    * SEES FY AFFO EARNINGS PER SHARE $1.51 - $1.53
    * SEES FY NAFFO EARNINGS PER SHARE $1.53 - $1.55
    * FY2021 FFO PER SHARE VIEW $1.62 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBw8swhVJa 
Further company coverage:  SBRA.O 

 ((Reuters.Briefs@thomsonreuters.com;))